CN104491682A - 一种治疗抽动症的药物及其制备方法 - Google Patents
一种治疗抽动症的药物及其制备方法 Download PDFInfo
- Publication number
- CN104491682A CN104491682A CN201410703948.3A CN201410703948A CN104491682A CN 104491682 A CN104491682 A CN 104491682A CN 201410703948 A CN201410703948 A CN 201410703948A CN 104491682 A CN104491682 A CN 104491682A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- liver
- flos
- tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 229940079593 drugs Drugs 0.000 title claims description 15
- 201000004572 transient tic disease Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 241000628997 Flos Species 0.000 claims description 42
- 239000008187 granular material Substances 0.000 claims description 26
- 239000002775 capsule Substances 0.000 claims description 25
- 239000003826 tablet Substances 0.000 claims description 24
- 229940023488 Pill Drugs 0.000 claims description 20
- 239000006187 pill Substances 0.000 claims description 20
- 208000000323 Tourette Syndrome Diseases 0.000 claims description 19
- 235000012239 silicon dioxide Nutrition 0.000 claims description 16
- 210000000582 Semen Anatomy 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 235000012907 honey Nutrition 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 238000009495 sugar coating Methods 0.000 claims description 4
- 210000004185 Liver Anatomy 0.000 abstract description 27
- 230000000694 effects Effects 0.000 abstract description 17
- 208000002193 Pain Diseases 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 13
- 230000036407 pain Effects 0.000 abstract description 13
- 210000004369 Blood Anatomy 0.000 abstract description 12
- 201000010874 syndrome Diseases 0.000 abstract description 11
- 210000002216 Heart Anatomy 0.000 abstract description 10
- 238000003756 stirring Methods 0.000 abstract description 7
- 230000002936 tranquilizing Effects 0.000 abstract description 4
- 241000668709 Dipterocarpus costatus Species 0.000 abstract description 3
- 241000544682 Acorus tatarinowii Species 0.000 abstract 1
- 241000123846 Buddleja officinalis Species 0.000 abstract 1
- 240000008365 Celosia argentea Species 0.000 abstract 1
- 235000000722 Celosia argentea Nutrition 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 240000007646 Chrysanthemum x morifolium Species 0.000 abstract 1
- 235000005986 Chrysanthemum x morifolium Nutrition 0.000 abstract 1
- 240000002123 Curcuma aromatica Species 0.000 abstract 1
- 235000003398 Curcuma aromatica Nutrition 0.000 abstract 1
- 240000009117 Eriocaulon cinereum Species 0.000 abstract 1
- 240000004600 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 240000001816 Prunella vulgaris Species 0.000 abstract 1
- 235000010674 Prunella vulgaris Nutrition 0.000 abstract 1
- 230000004377 improving vision Effects 0.000 abstract 1
- 230000000754 repressing Effects 0.000 abstract 1
- 231100000486 side effect Toxicity 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000036461 convulsion Effects 0.000 description 19
- 241000508725 Elymus repens Species 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 208000002173 Dizziness Diseases 0.000 description 8
- 206010015037 Epilepsy Diseases 0.000 description 7
- 241000475481 Nebula Species 0.000 description 7
- 206010043835 Tic disease Diseases 0.000 description 7
- 206010010904 Convulsion Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 6
- 230000004438 eyesight Effects 0.000 description 6
- 230000001737 promoting Effects 0.000 description 6
- 230000001629 suppression Effects 0.000 description 6
- 206010010071 Coma Diseases 0.000 description 4
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 description 4
- 206010019233 Headache Diseases 0.000 description 4
- 206010044126 Tourette's disease Diseases 0.000 description 4
- 230000001914 calming Effects 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 238000002651 drug therapy Methods 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 210000000481 Breast Anatomy 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010011878 Deafness Diseases 0.000 description 3
- 210000003414 Extremities Anatomy 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 210000003734 Kidney Anatomy 0.000 description 3
- 206010044565 Tremor Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000001815 facial Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 230000002522 swelling Effects 0.000 description 3
- 210000001015 Abdomen Anatomy 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 210000001124 Body Fluids Anatomy 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010010964 Coprolalia Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000001848 Dysentery Diseases 0.000 description 2
- 208000001780 Epistaxis Diseases 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N Haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- 206010021750 Infantile spasms Diseases 0.000 description 2
- 206010022437 Insomnia Diseases 0.000 description 2
- 210000004072 Lung Anatomy 0.000 description 2
- 206010027327 Menstrual disease Diseases 0.000 description 2
- 206010028347 Muscle twitching Diseases 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000008234 Tics Diseases 0.000 description 2
- 206010052769 Vertigos Diseases 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 201000010530 chronic tic disease Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 230000003203 everyday Effects 0.000 description 2
- 229960003878 haloperidol Drugs 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 201000008125 pain agnosia Diseases 0.000 description 2
- 230000001717 pathogenic Effects 0.000 description 2
- 230000003389 potentiating Effects 0.000 description 2
- 238000001671 psychotherapy Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002048 spasmolytic Effects 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- GJSURZIOUXUGAL-UHFFFAOYSA-N 2-((2,6-Dichlorophenyl)imino)imidazolidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 206010000059 Abdominal discomfort Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 210000001367 Arteries Anatomy 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003549 Asthenia Diseases 0.000 description 1
- 206010049848 Balance disease Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 210000004556 Brain Anatomy 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- 208000006922 Drug-Related Side Effects and Adverse Reaction Diseases 0.000 description 1
- 206010013781 Dry mouth Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 210000001097 Facial Muscles Anatomy 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 210000000232 Gallbladder Anatomy 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 206010018830 Haematemesis Diseases 0.000 description 1
- 210000003128 Head Anatomy 0.000 description 1
- 208000006750 Hematuria Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000005252 Hepatitis A Diseases 0.000 description 1
- 206010019780 Hepatitis infectious Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010061284 Mental disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028334 Muscle spasms Diseases 0.000 description 1
- 208000003067 Myocardial Ischemia Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000008425 Protein Deficiency Diseases 0.000 description 1
- 241000112598 Pseudoblennius percoides Species 0.000 description 1
- 210000004915 Pus Anatomy 0.000 description 1
- 206010037844 Rash Diseases 0.000 description 1
- 206010039083 Rhinitis Diseases 0.000 description 1
- RAPZEAPATHNIPO-UHFFFAOYSA-N Risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 1
- 229960001534 Risperidone Drugs 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042772 Syncope Diseases 0.000 description 1
- -1 Tai Bili Chemical compound 0.000 description 1
- VXMKYRQZQXVKGB-CWWHNZPOSA-N Tannin Chemical compound O([C@H]1[C@H]([C@@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)O[C@H]([C@H]2O)O1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 VXMKYRQZQXVKGB-CWWHNZPOSA-N 0.000 description 1
- 210000001138 Tears Anatomy 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000004371 Toothache Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 231100000765 Toxin Toxicity 0.000 description 1
- 206010068760 Ulcers Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 210000003462 Veins Anatomy 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 231100000494 adverse effect Toxicity 0.000 description 1
- 230000003042 antagnostic Effects 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000002429 anti-coagulation Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 230000001754 anti-pyretic Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 201000004569 blindness Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 230000002354 daily Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000916 dilatatory Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000005977 erythrokeratodermia variabilis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 238000011068 load Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002107 myocardial Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000001020 rhythmical Effects 0.000 description 1
- 230000001340 slower Effects 0.000 description 1
- 230000002269 spontaneous Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N β-Sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Abstract
一种治疗抽动症的药物及其制备方法,它是由制远志、蝉蜕、炒白芍、青葙子、夏枯草、生地黄、春柴胡、石菖蒲、白芷、菊花、密蒙花、天竺黄、谷精草、郁金按照一定比例配伍而成。本发明中药组合物能够补血养血、平抑肝阳、柔肝止痛、疏风平肝,宁心安神,清肝明目退翳,对治疗肝风内动证具有切实疗效,同时,也对治疗儿童、青少年抽动症具有切实疗效。药物价格低,效果好,而且无副作用。
Description
技术领域
本发明涉及一种由中草药为原料药的中药组合物及其制备方法,具体的说是涉及一种治疗抽动症的药物及其制备方法。
背景技术
抽动症一般指小儿抽动症。小儿抽动症即小儿多发性抽动症(MT)也称抽动秽语综合征、Tourette综合征、发声与多种运动联合抽动障碍、多发性抽动症,是抽动障碍的一个临床类型。
抽动障碍是一种起病于儿童和青少年期,以快速、不自主、突发、重复、非节律性、刻板、单一或多部位肌肉运动抽动或(和)发声抽动为特点的一种复杂的、慢性神经精神障碍。根据发病年龄、病程、临床表现和是否伴有发声抽动分为短暂性抽动障碍、慢性运动或发声抽动障碍、Tourette综合征三种临床类型。
该症多数起病于学龄期,学龄前期并不少见,低于5岁发病者可达40%。运动抽动常在7岁前发病,发声抽动发声较晚,多在11岁以前发生。国内报道8岁~12岁人群中抽动障碍患病率2.42‰。男性学龄儿童患病危险性最高,男女患病比率为3:1~4:1。国外报道学龄儿童抽动障碍的患病率12%~16%。学龄儿童中曾有短暂性抽动障碍病史者占5%~24%,慢性运动或发声抽动障碍患病率1%~2%,Tourette综合征终身患病率4/万~5/万。
该症临床特征是以进行性发展的多部位运动抽动和发声抽动为主要特征。一般首发症状为简单运动抽动,以面部肌肉的抽动最多,呈间断性,少数患者的首发症状为简单的发声抽动。随病程进展,抽动的部位增多,逐渐累及到肩部、颈部、四肢或躯干等部位,表现形式也由简单抽动发展为复杂抽动,由单一运动抽动或发声抽动发展成两者兼有,发生频度也增加。其中约30%出现秽语症或猥亵行为。多数患者每天都有抽动发生,少数患者的抽动呈间断性,但发作间隙期不会超过2月。病程持续迁延,超过一年以上,对患者的社会功能影响很大。
抽动症状严重影响了日常生活和学习者,目前多以药物治疗为主,结合心理治疗。药物治疗多以氟哌啶醇 、泰必利 、可乐定 、利培酮等药物治疗,但是这些药物副作用较大,常见副作用为嗜睡、乏力、头昏、胃肠道不适、兴奋、失眠、低血压、口干等,氟哌啶醇和利培酮有镇静和锥体外系副作用。而心理治疗成效并不理想。
发明内容
本发明从临床医疗用药需求及中医组方辩证原则出发,提出一种治疗抽动症的药物及其制备方法。它是由以下重量份数配比的原料药制备而成的药剂:制远志8-12g、蝉蜕3-7g、炒白芍13-17g、青葙子8-12、夏枯草3-7g、生地黄8-12g、春柴胡4-8g、石菖蒲8-12g、白芷8-12g、菊花8-12g、密蒙花8-12g、天竺黄8-12g、谷精草8-12g、郁金8-12g。优选配比为:制远志10g、蝉蜕5g、炒白芍15g、青葙子10、夏枯草5g、生地黄10g、春柴胡6g、石菖蒲10g、白芷10g、菊花10g、密蒙花10g、天竺黄10g、谷精草10g、郁金10g。所述药剂为汤剂、胶囊剂、片剂或丸剂。
所述胶囊剂、片剂、丸剂的制备方法步骤如下:
(1)取方中制远志、蝉蜕、炒白芍、青葙子、夏枯草、生地黄、春柴胡、石菖蒲、白芷、菊花、密蒙花、天竺黄、谷精草、郁金粉碎筛析;
(2)将步骤(1)中筛制的混合物加水煎煮2-3次,合并煎液、过滤,将虑液浓缩成70-80度时,胶囊、丸剂相对密度为1.0-1.6的稠膏,片剂相对密度为1.0-1.4的稠膏;
(3)制作胶囊、丸剂时:
将稠膏分离纯化、干燥,制成干颗粒;将干颗粒混合均匀,填充胶囊内即制成胶囊;将干颗粒喷加炼蜜、混合均匀,制成小丸即制成丸剂;
制作片剂时:
将2-4份淀粉与步骤(2)中的稠膏混合均匀,制成颗粒、干燥,制成干颗粒,将干颗粒压制成片剂,包糖衣,即制成片剂。
步骤(2)中所述的混合物,加水煎煮的优选次数为2次,第一次为60-80分钟,第二次为40-60分钟。
本发明药物原料药的药理如下:
制远志:归经: 归心、肾、肺经。具有安神益智、祛痰、消肿的功能,用于心肾不交引起的失眠多梦、健忘惊悸,神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛。制远志又名泡远志、清远志。为净远志在甘草煎液中浸泡后,捞出晒干入药者。偏于宁心安神。
蝉蜕:轻,中空,易碎。无臭,味淡。功能:宣散风热、透疹利咽、退翳明目、祛风止痉。
炒白芍:[药性功效] 白芍性凉,味苦酸,微寒,具有补血养血、平抑肝阳、柔肝止痛、敛阴止汗等功效,适用于阴虚发热、月经不调、胸腹胁肋疼痛、四肢挛急,泻痢腹痛、自汗盗汗、崩漏、带下等症。其化学成分包含芍药甙、牡丹酚、芍药花甙,尚含苯甲酸、挥发油、脂肪油、树脂、鞣质、糖、淀粉、粘液质、蛋白质、β-谷甾醇和三萜类等。芍药甙有抗菌、解热、抗炎、增加冠状动脉流量、改善心肌营养血流、扩张血管、对抗急性心肌缺血、抑制血小板聚集、镇静、镇痛、解痉、抗溃疡、调节血糖的作用。治疗肌肉痉挛。
青葙子:归肝经。[功能主治]清肝,明目,退翳。用于肝热目赤,眼生翳膜,视物昏花,肝火眩晕。
夏枯草:【药性】辛、苦,寒。归肝、胆经。【功效】清热泻火,明目,散结消肿。治口眼歪斜、治羊痫风、高血压、治头目眩晕。
生地黄:生地黄,清热凉血,养阴,生津;用于热病烦渴、发斑发疹、阴虚内热、吐血、衄血、糖尿病、传染性肝炎。
春柴胡:有和解表里,疏肝,升阳之功效,可治寒热往来,胸满胁痛,口苦耳聋,头痛目眩,疟疾,下利脱肛,月经不调,子宫下垂。
石菖蒲:【功能主治】化湿开胃,开窍豁痰,醒神益智。用于脘痞不饥,噤口下痢,神昏癫痫,健忘耳聋。理气,活血,散风,去湿。治癫痫,痰厥,热病神昏,健忘,气闭耳聋,心胸烦闷,胃痛,腹痛,风寒湿痹,痈疽肿毒,跌打损伤。可用于治癫痫、治少小热风痫、治心气不定。
白芷:以根入药,有祛病除湿、排脓生肌、活血止痛等功能。主治风寒感冒、头痛、鼻炎、牙痛,赤白带下、痛疖肿毒等症。
菊花:有疏风、平肝之功效。
密蒙花:有祛风、凉血、润肝、明目的作用,可治目赤肿痛,多泪羞明,青盲翳障,风弦烂眼。
天竺黄:【功能主治】清热豁痰,凉心定惊。主治:热病神昏谵妄,中风痰迷不语,小儿惊风抽搐,癫痫。 痰热咳嗽。因为天竺黄自然产出者很少,因此本发明药物中天竺黄采用人工方法制造。
谷精草:功效:祛风散热,明目退翳。用于肝经风热、目赤肿痛、目生翳障、风热头痛、夜盲症等。
郁金:【归经】入心、肺、肝经。【功能主治】行气解郁,凉血破瘀。治胸腹胁肋诸痛,失心癫狂,热病神昏,吐血,衄血,尿血,血淋,妇女倒经,黄疸。
治疗抽动症,一定程度上,中医多以治疗肝风内动证实现。肝风内动证是指临床出现眩晕欲仆,震颤,抽搐等症状的病证。肝风内动,病证名。指肝风不因外感风邪而动者。泛指因风阳、火热、阴血亏虚所致,以肢体抽搐、眩晕、震颤等为主要表现的症候。《素问·至真要大论》:“诸风掉眩,皆属于肝。”《临证指南医案·肝风》华岫云按:“倘精液有亏,肝阴不足,血燥生热,热则风阳上升,窍络阻塞,头目不清,眩晕跌仆,甚则瘈疭痉厥矣。”肝风内动可分虚实,虚证有阴虚动风,血虚生风;实证有肝阳化风,热极生风。
因此,本发明以炒白芍为君药,补血养血、平抑肝阳、柔肝止痛、敛阴止汗,镇静、镇痛、解痉。以制远志、青葙子、生地黄、石菖蒲、白芷、菊花、密蒙花、天竺黄、谷精草、郁金,疏风平肝,宁心安神,清肝明目退翳,清热凉血,养阴生津,消除烦躁,化湿开胃,开窍豁痰,醒神益智,祛病除湿,活血止痛,清热豁痰,凉心定惊,祛风散热,行气解郁,凉血破瘀。佐使以春柴胡、蝉蜕、夏枯草。和解表里,疏肝升阳,宣散风热,退翳明目,祛风止痉,清热泻火,散结消肿。治口眼歪斜、羊痫风、头目眩晕。本发明所述的药物承中医之精髓:严谨组方,诸药君臣佐使合用,补破结合:相得益彰,符合中医用药规律和辨证施治的原则。
有益效果
本发明中药组合物能够补血养血、平抑肝阳、柔肝止痛、疏风平肝,宁心安神,清肝明目退翳,对治疗肝风内动证具有切实疗效,同时,也对治疗儿童、青少年抽动症具有切实疗效。药物价格低,效果好,而且无副作用。
为了更好的理解本发明药物的疗效,现将2012-2014年2月使用本发明药物治疗的临床疗效数据统计如下:
病例筛选
共计124例
7-12岁儿童,26例;
13-21岁青少年:79例;
45-89岁中、老年:19例。
诊断方法
儿童,青少年临床症状以间断性肌肉抽动为主,部分患者临床出现眩晕、头痛、耳鸣、口眼歪斜、或手足麻木、振颤、偏瘫,或抽搐、瘈疭,舌多红绛、干燥,脉多细数无力或弦细。
治疗方案
服用本发明实施例2所制胶囊,饭后半小时后服用,每天早中晚三次,每次4-5粒,每粒0.3g。15天为一个疗程。
疗效评价
治愈:临床症状全部消失;
有效:临床症状明显减少或减缓,间隔拉长;
无效:临床症状无明显变化,或加重;
总有效率=治愈率+有效率。
统计结果
病例数 | 治愈 | 有效 | 无效 | 治愈率 | 总有效率 |
124例 | 81 | 26 | 18 | 65.32% | 86.29% |
结论
通过对2012-2014年2月使用本发明药物治疗的124例临床疗效数据进行统计,显示,治愈81例,治愈率为65.32%,有效26例,18例无效,总有效率为86.29%。从统计结果可以看出,本发明药物对治疗肝风内动证,治疗儿童、青少年抽动症具有切实疗效。
从多年的临床试验与使用效果看,本发明药物能有有效治疗或缓解抽动症,药物价格低,效果好,而且无副作用。
急毒性试验:较大剂量和较长疗程服用对大鼠的生长无显著毒性,对大鼠的脑:心:肝:肾等切片形态学检查未见明显毒性损伤改变,试验显示,本药物毒性甚小。
具体实施方式
实施例1:一种治疗抽动症的药物及其制备方法。它是由以下重量份数配比的原料药制备而成的药剂:制远志8-12g、蝉蜕3-7g、炒白芍13-17g、青葙子8-12、夏枯草3-7g、生地黄8-12g、春柴胡4-8g、石菖蒲8-12g、白芷8-12g、菊花8-12g、密蒙花8-12g、天竺黄8-12g、谷精草8-12g、郁金8-12g。所述药剂为胶囊剂:片剂或丸剂。
按照下述重量份数配比称取原料药:
制远志8-12g、蝉蜕3-7g、炒白芍13-17g、青葙子8-12、夏枯草3-7g、生地黄8-12g、春柴胡4-8g、石菖蒲8-12g、白芷8-12g、菊花8-12g、密蒙花8-12g、天竺黄8-12g、谷精草8-12g、郁金8-12g。
所述胶囊剂:片剂:丸剂的制备方法步骤如下:
(1)取方中制远志、蝉蜕、炒白芍、青葙子、夏枯草、生地黄、春柴胡、石菖蒲、白芷、菊花、密蒙花、天竺黄、谷精草、郁金粉碎筛析;
(2)将步骤(1)中筛制的混合物加水煎煮2-3次,合并煎液:过滤,将虑液浓缩成70-80度时,胶囊:丸剂相对密度为1.0-1.6的稠膏,片剂相对密度为1.0-1.4的稠膏;
(3)制作胶囊:丸剂时:
将稠膏分离纯化:干燥,制成干颗粒;将干颗粒混合均匀,填充胶囊内即制成胶囊;将干颗粒喷加炼蜜:混合均匀,制成小丸即制成丸剂;
制作片剂时:
将2-4份淀粉与步骤(2)中的稠膏混合均匀,制成颗粒:干燥,制成干颗粒,将干颗粒压制成片剂,包糖衣,即制成片剂。
步骤(2)中所述的混合物,加水煎煮的优选次数为2次,第一次为60-80分钟,第二次为40-60分钟。
本发明药剂形态还可以为汤剂、口服液、颗粒剂等剂型。
实施例2:一种治疗抽动症的药物及其制备方法。它是由以下重量份数配比的原料药制备而成的药剂:制远志10g、蝉蜕5g、炒白芍15g、青葙子10、夏枯草5g、生地黄10g、春柴胡6g、石菖蒲10g、白芷10g、菊花10g、密蒙花10g、天竺黄10g、谷精草10g、郁金10g。所述药剂为胶囊剂:片剂或丸剂。
按照下述重量份数配比称取原料药:
制远志10g、蝉蜕5g、炒白芍15g、青葙子10、夏枯草5g、生地黄10g、春柴胡6g、石菖蒲10g、白芷10g、菊花10g、密蒙花10g、天竺黄10g、谷精草10g、郁金10g。
所述胶囊剂:片剂:丸剂的制备方法步骤如下:
(1)取方中制远志、蝉蜕、炒白芍、青葙子、夏枯草、生地黄、春柴胡、石菖蒲、白芷、菊花、密蒙花、天竺黄、谷精草、郁金粉碎筛析;
(2)将步骤(1)中筛制的混合物加水煎煮2-3次,合并煎液:过滤,将虑液浓缩成70-80度时,胶囊:丸剂相对密度为1.0-1.6的稠膏,片剂相对密度为1.0-1.4的稠膏;
(3)制作胶囊:丸剂时:
将稠膏分离纯化:干燥,制成干颗粒;将干颗粒混合均匀,填充胶囊内即制成胶囊;将干颗粒喷加炼蜜:混合均匀,制成小丸即制成丸剂;
制作片剂时:
将2-4份淀粉与步骤(2)中的稠膏混合均匀,制成颗粒:干燥,制成干颗粒,将干颗粒压制成片剂,包糖衣,即制成片剂。
步骤(2)中所述的混合物,加水煎煮的优选次数为2次,第一次为60-80分钟,第二次为40-60分钟。
本发明药剂形态还可以为汤剂、口服液、颗粒剂等剂型。
Claims (5)
1.一种治疗抽动症的药物,其特征在于它是由以下重量份数配比的原料药制备而成的药剂:制远志8-12g、蝉蜕3-7g、炒白芍13-17g、青葙子8-12、夏枯草3-7g、生地黄8-12g、春柴胡4-8g、石菖蒲8-12g、白芷8-12g、菊花8-12g、密蒙花8-12g、天竺黄8-12g、谷精草8-12g、郁金8-12g。
2.根据权利要求1所述的治疗抽动症的药物,其特征在于它是由以下重量份数配比的原料药制备而成的药剂:制远志10g、蝉蜕5g、炒白芍15g、青葙子10、夏枯草5g、生地黄10g、春柴胡6g、石菖蒲10g、白芷10g、菊花10g、密蒙花10g、天竺黄10g、谷精草10g、郁金10g。
3.根据权利要求1或2所述的治疗抽动症的药物,其特征在于:所述药剂为汤剂、胶囊剂、片剂或丸剂。
4.根据权利要求3所述的治疗抽动症的药物,其特征在于:所述胶囊剂、片剂、丸剂的制备方法步骤如下:
(1)取方中制远志、蝉蜕、炒白芍、青葙子、夏枯草、生地黄、春柴胡、石菖蒲、白芷、菊花、密蒙花、天竺黄、谷精草、郁金粉碎筛析;
(2)将步骤(1)中筛制的混合物加水煎煮2-3次,合并煎液、过滤,将虑液浓缩成70-80度时,胶囊、丸剂相对密度为1.0-1.6的稠膏,片剂相对密度为1.0-1.4的稠膏;
(3)制作胶囊、丸剂时:
将稠膏分离纯化、干燥,制成干颗粒;将干颗粒混合均匀,填充胶囊内即制成胶囊;将干颗粒喷加炼蜜、混合均匀,制成小丸即制成丸剂;
制作片剂时:
将2-4份淀粉与步骤(2)中的稠膏混合均匀,制成颗粒、干燥,制成干颗粒,将干颗粒压制成片剂,包糖衣,即制成片剂。
5.根据权利要求4所述的治疗抽动症的药物的制备方法,其特征在于步骤(2)中所述的混合物,加水煎煮的次数为2次,第一次为60-80分钟,第二次为40-60分钟。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410703948.3A CN104491682A (zh) | 2014-11-30 | 2014-11-30 | 一种治疗抽动症的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410703948.3A CN104491682A (zh) | 2014-11-30 | 2014-11-30 | 一种治疗抽动症的药物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104491682A true CN104491682A (zh) | 2015-04-08 |
Family
ID=52933196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410703948.3A Pending CN104491682A (zh) | 2014-11-30 | 2014-11-30 | 一种治疗抽动症的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104491682A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106474347A (zh) * | 2016-12-06 | 2017-03-08 | 郑卫强 | 一种治疗小儿抽动症的中成药 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130040578A (ko) * | 2011-10-14 | 2013-04-24 | 주식회사한국전통의학연구소 | 생약 추출물을 포함하는 간암 예방 또는 치료용 약학적 조성물 |
CN103977288A (zh) * | 2014-05-30 | 2014-08-13 | 刘士和 | 一种治疗多发性抽动症的药物及其制备方法 |
-
2014
- 2014-11-30 CN CN201410703948.3A patent/CN104491682A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130040578A (ko) * | 2011-10-14 | 2013-04-24 | 주식회사한국전통의학연구소 | 생약 추출물을 포함하는 간암 예방 또는 치료용 약학적 조성물 |
CN103977288A (zh) * | 2014-05-30 | 2014-08-13 | 刘士和 | 一种治疗多发性抽动症的药物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
朱先康等: ""定抽颗粒"治疗小儿多发性抽动症30例临床观察", 《江苏中医药》 * |
肖旭腾等: "定风安神汤治疗儿童抽动症46例疗效观察", 《新中医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106474347A (zh) * | 2016-12-06 | 2017-03-08 | 郑卫强 | 一种治疗小儿抽动症的中成药 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105998297A (zh) | 一种润肠通便的中药组合物及其制备方法 | |
CN104825914A (zh) | 一种辅助治疗乳腺癌症的中药制剂 | |
CN103860659A (zh) | 治疗早期肾结石的中药 | |
CN103735937B (zh) | 具有促进铁成分吸收并且补血的药物及保健品 | |
CN104548049A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
CN104524174A (zh) | 一种治疗风湿痹痛的中药组合物及其制备方法 | |
CN104491682A (zh) | 一种治疗抽动症的药物及其制备方法 | |
CN103919966B (zh) | 一种治疗痤疮的药物 | |
CN103463467B (zh) | 一种具有滋补肾阴功效的苗方药酒 | |
CN103202964B (zh) | 益脑安神药酒 | |
CN103432274B (zh) | 一种治疗偏头痛的药物及其制备方法 | |
CN105362689A (zh) | 一种治疗脾肾两虚型缺血性脑卒中后血管性痴呆的中药组合物 | |
CN102293941B (zh) | 一种治疗糖尿病的中药组合物 | |
CN104689240A (zh) | 一种治疗气滞血瘀型黄褐斑的药物及其制备方法 | |
CN103550530B (zh) | 一种治疗偏头痛的中药组合物 | |
CN102626503B (zh) | 一种舒心益智的中药口服液 | |
CN105434987A (zh) | 一种治疗脑梗塞的中药制剂 | |
CN105596697A (zh) | 一种用于治疗儿童多发性抽动症的中药冲剂及制备方法 | |
CN105343647A (zh) | 一种治疗神经衰弱的中药制剂 | |
CN104707031A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
CN104027741A (zh) | 一种口服治疗女性髌骨软化症中药组合物 | |
CN104524090A (zh) | 一种治疗头部损伤后遗症的中药制剂 | |
CN102743709B (zh) | 一种治疗风邪入侵眶上神经痛的中药制剂及其制备方法 | |
CN104225560A (zh) | 一种治疗胸阳痹阻型冠心病的中药组合物及其制备方法 | |
CN104435232B (zh) | 一种用于治疗牙痛的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150408 |
|
WD01 | Invention patent application deemed withdrawn after publication |